Susquehanna International Group
KZR

Susquehanna International Group’s Kezar Life Sciences KZR Stock Holding History

Susquehanna International Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$384K Buy
+51,800
New +$337K ﹤0.01% 10309
2023
Q2 		– Sell
-1,850
Closed -$57.9K – 12664
2023
Q1 		$57.9K Buy
+1,850
New +$107K ﹤0.01% 11628
2022
Q3 		– Sell
-12,420
Closed -$1.03M – 13704
2022
Q2 		$1.03M Buy
12,420
+1,960
+19% +$173K ﹤0.01% 6483
2022
Q1 		$1.74M Buy
+10,460
New +$1.5M ﹤0.01% 5793
2021
Q2 		– Sell
-1,190
Closed -$71K – 12950
2021
Q1 		$71K Buy
+1,190
New +$69.6K ﹤0.01% 11966
2020
Q3 		– Sell
-5,130
Closed -$266K – 10868
2020
Q2 		$266K Buy
+5,130
New +$259K ﹤0.01% 8564

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Susquehanna International Group's KZR Position: Q4 2024 in Review

Susquehanna International Group sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 1,259 shares — an estimated $9.38K sold.

Susquehanna International Group first reported a position in KZR in Q1 2020 and held it in 16 quarters. The position peaked at $1.1M in Q1 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.

  • Susquehanna International Group reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 1,259 Kezar Life Sciences shares in Q4 2024, an estimated $9.38K.
  • Susquehanna International Group first reported a position in Kezar Life Sciences in Q1 2020 and held it in 16 quarters.
  • Susquehanna International Group's Kezar Life Sciences position peaked at $1.1M in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.